INCY
Incyte Corporation
NASDAQ: INCY · HEALTHCARE · BIOTECHNOLOGY
$99.10
+1.39% today
Updated 2026-04-29
Market cap
$19.80B
P/E ratio
14.00
P/S ratio
3.69x
EPS (TTM)
$7.08
Dividend yield
—
52W range
$58 – $112
Volume
1.6M
Incyte Corporation (INCY) Financial statements
SEC filings — annual and quarterly data.
Profit margin
26.70%
Operating margin
25.50%
ROE
30.80%
ROA
13.90%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $27.64M | $-74.17M | 100.00% | -267.57% | -268.30% |
| 2007 | $34.44M | $-86.88M | 100.00% | -248.20% | -252.27% |
| 2008 | $3.92M | $-178.92M | 100.00% | -4,070.32% | -4,565.45% |
| 2009 | $9.27M | $-211.87M | 100.00% | -1,486.85% | -2,286.78% |
| 2010 | $169.88M | $-31.85M | 100.00% | 8.05% | -18.75% |
| 2011 | $94.45M | $-186.54M | 100.00% | -151.59% | -197.49% |
| 2012 | $297.06M | $-44.32M | 89.86% | 0.39% | -14.92% |
| 2013 | $354.95M | $-83.15M | 91.59% | -4.54% | -23.43% |
| 2014 | $511.50M | $-48.48M | 91.32% | -0.94% | -9.48% |
| 2015 | $753.75M | $6.53M | 93.44% | 6.72% | 0.87% |
| 2016 | $1.11B | $104.22M | 90.59% | 14.83% | 9.43% |
| 2017 | $1.54B | $-313.14M | 92.83% | -15.34% | -20.38% |
| 2018 | $1.88B | $109.49M | 93.22% | 8.26% | 5.82% |
| 2019 | $2.16B | $446.91M | 93.18% | 19.53% | 20.70% |
| 2020 | $2.67B | $-295.70M | 93.94% | -9.01% | -11.09% |
| 2021 | $2.99B | $948.58M | 93.73% | 21.35% | 31.76% |
| 2022 | $3.39B | $340.66M | 92.54% | 17.66% | 10.04% |
| 2023 | $3.70B | $597.60M | 91.47% | 17.64% | 16.17% |
| 2024 | $4.24B | $32.62M | 91.09% | 1.89% | 0.77% |
| 2025 | $5.14B | $1.29B | 91.47% | 26.12% | 25.03% |